University Hospital of Umeå, in Swedish Norrlands universitetssjukhus, is the major hospital in northern Sweden, situated in Umeå. The hospital employs 5,600 people.

During the past decade, Norrlands universitetssjukhus; Onkologkliniken conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Norrlands universitetssjukhus; Onkologkliniken" #1 collaborator was "A+ Science AB" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Norrlands universitetssjukhus; Onkologkliniken" are "Atrophy" (1 trials), "Basal Cell Carcinoma" (1 trials), "Breast Cancer" (1 trials), "Kidney Neoplasms" (1 trials) and "Malignant Melanoma" (1 trials). Many other conditions were trialed in "Norrlands universitetssjukhus; Onkologkliniken" in a lesser frequency.

Most popular intervention types in "Norrlands universitetssjukhus; Onkologkliniken" are "Drug" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Axitinib (AG-013736)" (1 trials), "Bevacizumab" (1 trials), "Oxytocin" (1 trials) and "Oxytocin 400 IU vaginal gel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Norrlands universitetssjukhus; Onkologkliniken" are 5 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Norrlands universitetssjukhus; Onkologkliniken". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Norrlands universitetssjukhus; Onkologkliniken, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Norrlands universitetssjukhus; Onkologkliniken, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".